Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Sep 15, 2024; 16(9): 3887-3897
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.3887
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.3887
Figure 4 Short-term efficacy assessment.
A: Comparison of complete pathological response (pCR) between the dexamethasone and antihistamine groups. The P value is 0.268, indicating no statistically significant difference between the two groups; B: Comparison of major pathological response (MPR) between the dexamethasone and antihistamine groups. The P value is 0.416, indicating no statistically significant difference between the two groups; C: Comparison of pCR between the < 20 mg dexamethasone group and the 20 mg dexamethasone group. The P value is 0.928, indicating no statistically significant difference between the two dosage groups; D: Comparison of MPR between the < 20 mg dexamethasone group and the 20 mg dexamethasone group. The P value is 0.067, indicating no statistically significant difference between the two dosage groups. pCR: Complete pathological response; MPR: Major pathological response.
- Citation: Huang YH, Yang GZ, Chen HG, Li XJ, Wu YH, Zhang K, Xu JN, Zhang J. Impact of baseline steroids on the efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma. World J Gastrointest Oncol 2024; 16(9): 3887-3897
- URL: https://www.wjgnet.com/1948-5204/full/v16/i9/3887.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i9.3887